<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
  <title>The efficacy and underlying mechanism of phosphodiesterase- 5 inhibitors in preventing cognitive impairment and Alzheimer pathology: A systematic review of animal studies - VetSRev</title>
  <link rel="stylesheet" href="/vendor/bootstrap-4.3.1.min.css">
  <link rel="stylesheet" href="/vendor/fontawesome-5.8.1.min.css">

  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Roboto:ital,wght@0,100;0,300;0,400;0,700;1,400&display=swap" rel="stylesheet">

  <link rel="stylesheet" href="/assets/style.css" media="screen" type="text/css">

  <link rel="apple-touch-icon" sizes="180x180" href="/apple-touch-icon.png">
  <link rel="icon" type="image/png" sizes="32x32" href="/favicon-32x32.png">
  <link rel="icon" type="image/png" sizes="16x16" href="/favicon-16x16.png">
  <link rel="manifest" href="/site.webmanifest">
</head>

<body>
  <!-- HEADER -->
  <div class="header">
    <div class="container">
      <img src="/assets/CEVMLogo.png" alt="logo"/>
      <div class="title">
        <h1>VetSRev</h1>
        <p class="hidden-xs">Database of veterinary systematic reviews</p>
      </div>
    </div>
  </div>

  <!-- Navigation -->
  <div class="container">
    <nav class="navbar navbar-expand navbar-light bg-light">
      <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarSupportedContent" aria-controls="navbarSupportedContent" aria-expanded="false" aria-label="Toggle navigation">
        <span class="navbar-toggler-icon"></span>
      </button>

      <div class="collapse navbar-collapse" id="navbarSupportedContent">
        <ul class="navbar-nav mr-auto">
          <li class="nav-item"><a class="nav-link" href="/">Home</a></li>
          <li class="nav-item"><a class="nav-link" href="/about.html">About the database</a></li>
        </ul>
      </div>
    </nav>
  </div>

  <!-- CONTENT -->
  <div class="container">
  <div class="publication">
  <h1>The efficacy and underlying mechanism of phosphodiesterase- 5 inhibitors in preventing cognitive impairment and Alzheimer pathology: A systematic review of animal studies</h1>
  <h2>El-Bakly, W. and Wagdy, O. and Sobhy, A. and Abo Elenain, O. and Riad, M. S. and El Sayed, M. and Tarkhan, S. and Yassen, M. and Mahmoud, A. and Bassiony, M. and Nabil, N.</h2>

  
  <p>Behav Brain Res (2019) 372: 112004</p>
  

  
  <p>DOI: <a href="https://doi.org/10.1016/j.bbr.2019.112004">10.1016/j.bbr.2019.112004</a></p>
  

  
  <h2>Abstract</h2>
  <p>BACKGROUND: Alzheimer disease (AD) initially presents with cognitive decline that affects the affected individual’s daily activities. Cognitive decline reversal represents an important medical need, where Phosphodiesterase-5 inhibitors (PDE-5Is) might play a role. AIM: This systematic review was performed to verify the efficacy of PDE-5Is in preventing cognitive impairment and to elucidate the underlying mechanism. METHODS: Preclinical animal studies assessing the efficacy of PDE-5Is in preventing cognitive impairment and pathological changes by measuring Aβ-42 β42 and p-Tau were included in the analysis. CAMARADES Checklist was used to assess study quality. Further, various signaling pathways in different studies were examined. RESULTS AND OUTCOMES: Data of behavioral tests were extracted and a meta-analysis was conducted. Fifteen animal trials met the inclusion criteria, and all reported the prevention of cognitive deficits by PDE-5Is in Alzheimer’s disease. A significant effect of PDE-5Is in increasing the time spent in the target quadrant was reported in four of seven studies using the water maze. Four studies showed significant improvement in contextual fear memory freezing time, and three studies showed improvement in the 14 unit maze number of errors. CONCLUSIONS: Cognitive decline in preclinical AD finds tauopathy has a more impact than Aβ-42. This systematic review showed that PDE-5 inhibitors might help prevent cognitive impairment in AD, and while its mechanism of action is non-related to Aβ-42, it might include decrease p-Tau, increase CREB and BDNF or suppressing apoptosis and inflammation. However, the efficacy of PDE-5 inhibitors in preventing cognitive impairment remains unclear due to various limitations, such as the small number of included studies, the high risk of bias, the lack of an integrated study design, and low reporting quality.</p>
  

  <h2>Citation</h2>
  <p class="citation"><span id="el-bakly_efficacy_2019">El-Bakly, W., Wagdy, O., Sobhy, A., Abo Elenain, O., Riad, M. S., El Sayed, M., Tarkhan, S., Yassen, M., Mahmoud, A., Bassiony, M., &amp; Nabil, N. (2019). The efficacy and underlying mechanism of phosphodiesterase- 5 inhibitors in preventing cognitive impairment and Alzheimer pathology: A systematic review of animal studies. <i>Behav Brain Res</i>, <i>372</i>, 112004. https://doi.org/10.1016/j.bbr.2019.112004 <b>Animals, Disease Models, Animal, Amyloid beta-Peptides/metabolism, Memory/drug effects, *Cognition, *Alzheimer disease, *aβ-42 β, *mwm, *Phosphodiesterase-5 inhibitors, *T maize, Alzheimer Disease/metabolism/*pathology, Cognition Disorders/drug therapy/metabolism, Cognition/drug effects, Cognitive Dysfunction/*drug therapy/metabolism/prevention &amp; control, Cyclic Nucleotide Phosphodiesterases, Type 5/metabolism, Phosphodiesterase 5 Inhibitors/metabolism/*pharmacology, tau Proteins/metabolism</b></span> </p>


  <h2>Keywords</h2>
  <ul>
    
    
      <li>Animals</li>
    
      <li>Disease Models</li>
    
      <li>Animal</li>
    
      <li>Amyloid beta-Peptides/metabolism</li>
    
      <li>Memory/drug effects</li>
    
      <li>*Cognition</li>
    
      <li>*Alzheimer disease</li>
    
      <li>*aβ-42 β</li>
    
      <li>*mwm</li>
    
      <li>*Phosphodiesterase-5 inhibitors</li>
    
      <li>*T maize</li>
    
      <li>Alzheimer Disease/metabolism/*pathology</li>
    
      <li>Cognition Disorders/drug therapy/metabolism</li>
    
      <li>Cognition/drug effects</li>
    
      <li>Cognitive Dysfunction/*drug therapy/metabolism/prevention & control</li>
    
      <li>Cyclic Nucleotide Phosphodiesterases</li>
    
      <li>Type 5/metabolism</li>
    
      <li>Phosphodiesterase 5 Inhibitors/metabolism/*pharmacology</li>
    
      <li>tau Proteins/metabolism</li>
    
  </ul>

</div>

  </div>

  <!-- FOOTER -->
  <div class="container">
    <div class="footer">


      <h3>VetSRev</h3>
      <p class="strap">Database of veterinary systematic reviews</p>

      <p>To cite this resource please use the following:</br>
      Veterinary Systematic Review database (2021) VetSRev database (Version 2.0). Available at: https://vetsrev.nottingham.ac.uk.</p>


      <p class="smallprint"><a href="/cookies.html">Cookies policy</a></p>

    </div>
  </div>

  <!-- Cookie-Alert -->
  <div class="alert alert-dark alert-dismissible cookiealert" role="alert">

    We'd like to set some analytics cookies to help us improve our website.

    <a href="/cookies/">Learn more.</a>
    <button type="button" class="btn btn-outline-secondary btn-sm declinecookies" data-dismiss="alert">Decline</button>
    <button type="button" class="btn btn-primary btn-sm acceptcookies">Accept</button>

    <button type="button" class="close" data-dismiss="alert" aria-label="Close">
      <span aria-hidden="true">&times;</span>
    </button>
  </div>


  <!-- jQuery first, then Popper.js, then Bootstrap JS -->
  <script src="/vendor/jquery-3.5.1.min.js"></script>
  <script src="/vendor/popper.min.js "></script>
  <script src="/vendor/bootstrap-4.3.1.min.js "></script>

  


  


  <!-- cookies and Google Analytics-->
  <script src="/assets/cookies.js "></script>

</body>
</html>
